4D Molecular Therapeutics, Inc. — Form 8-K
Filed July 20, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
4D Molecular Therapeutics filed Form 8-K on July 20, 2026 reporting Other Events (Item 8.01) for period ending July 18, 2026. The actual event details are not disclosed in the provided filing header/metadata—only the document structure and administrative information are shown. No counterparties, dollar amounts, share counts, dates of material transactions, or specific business developments are stated in the available text.
Why this rating
Metadata-only 8-K with no substantive event description accessible; cannot assess materiality without actual disclosure content.
Extracted items
See more from July 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.